humburger icon

New and Updated MASCC Guidelines

Home > News > New and Updated MASCC Guidelines
New Guidelines and Guideline Summaries

New and Updated MASCC Guidelines

Our MASCC study groups have released several new sets of guidelines in 2024:

  1. The Antiemetics Study Group in collaboration with ESMO has updated the MASCC/ESMO Antiemetic Guidelines, including:
  • Emetic classification of antineoplastic agents
  • Highly emetic chemotherapy
  • Moderately emetic chemotherapy
  • Low or minimally emetic chemotherapy
  • Multiple-day, high-dose chemotherapy, refractory, break-through nausea and vomiting
  • CAMs and non-pharmacological interventions
  • Radiotherapy-induced nausea and vomiting

    2. The Oncodermatology and Survivorship Study Groups have created new MASCC clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL) based on international Delphi consensus-based recommendations.

    • All
    • Affiliates & Partners
    • Announcements
    • Annual Meeting
    • Centers of Excellence
    • Positions & Fellowships
    • Research Highlights